insights_auto
Why is SYRE down 2.43%?
Dive Deeperchevron_right
SYRE:NASDAQ
Spyre Therapeutics Inc
$96.56
arrow_downward
-2.43%(-2.40) 1D
$96.56
0.00% (0.00)
bedtimeAfter hours
Closed: Oct 30, 4:00:00 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SYRE...
Open
$96.78
High
$98.96
Low
$94.68
Mkt. cap
8.90B
Avg. vol.
1.40M
Volume
661.13K
52-wk high
$110.18
52-wk low
$21.15
EPS
-$2.32
Beta
3.10
Shares outstanding
92.29M
No. of employees
125
Open
$96.78
High
$98.96
Low
$94.68
Mkt. cap
8.90B
Avg. vol.
1.40M
Volume
661.13K
52-wk high
$110.18
52-wk low
$21.15
EPS
-$2.32
Beta
3.10
Shares outstanding
92.29M
No. of employees
125
News stories
From web sources and news partners
24/7 Wall St.
·
8 hours ago
S&P Says Meta Can’t Make Money From AI as Well as Its Rivals
TradingView
·
10 hours ago
Nifty 500 vs S&P 500: India or US, innovation is the only game in town for investors
BigGo Finance
·
12 hours ago
Nasdaq Plunges 748 Points in a Single Day; Experts Compare to 2000 Bubble: This Time It Hasn't Even Entered Correction Territory
The Motley Fool
·
21 hours ago
History Says No 20-Year Stretch in the S&P 500 Has Lost Money Since 1950. Here's What the Worst One Returned.
About Spyre Therapeutics Inc
CEO-
Employees125
FoundedJan 1, 2013
HeadquartersWaltham, Massachusetts, United States
SectorBiotechnology
Websitespyre.com